Drug Profile
Research programme: Huntington's disease therapy - NeuroSearch
Alternative Names: Ion channel modulator for Huntington's disease (NSD-726) - NeuroSearch/NsDiscovery; NSD-726Latest Information Update: 04 Dec 2013
Price :
$50
*
At a glance
- Originator NeuroSearch
- Class
- Mechanism of Action Ion channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Huntington's disease
Most Recent Events
- 28 Sep 2011 Research programme: Huntington's disease therapy - NeuroSearch is available for licensing as of 28 Sep 2011. http://neurosearch.com
- 30 Mar 2011 Preclinical development is ongoing in Denmark